pazopanib eye drops

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Macular Degeneration

Phase 1

Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops

CompletedNCT00659555

GlaxoSmithKlineMacular Degeneration

Start: 2008-04-04End: 2008-05-10Updated: 2017-11-13

Phase 2

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

CompletedNCT01134055

GlaxoSmithKlineMacular Degeneration

Start: 2010-06-01End: 2012-10-01Updated: 2018-01-08

12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)

TerminatedNCT01362348

GlaxoSmithKlineMacular Degeneration

Start: 2011-07-07End: 2012-04-16Updated: 2017-09-21